​

Eton Pharmaceuticals (ETON) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Eton Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$79.95M

Latest Revenue (Q)

$22.46M

Main Segment (Y)

Product Sales and Royalties

Eton Pharmaceuticals Revenue by Period

Eton Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$79.95M104.94%
2024-12-31$39.01M23.29%
2023-12-31$31.64M48.90%
2022-12-31$21.25M-2.66%
2021-12-31$21.83M55879.49%
2020-12-31$39.00K-95.93%
2019-12-31$959.00K100.00%
2018-12-31-100.00%
2017-12-31--

Eton Pharmaceuticals generated $79.95M in revenue during NA 2025, up 104.94% compared to the previous quarter, and up 205000.00% compared to the same period a year ago.

Eton Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30$22.46M18.65%
2025-06-30$18.93M9.52%
2025-03-31$17.28M48.38%
2024-12-31$11.65M12.81%
2024-09-30$10.32M13.78%
2024-06-30$9.07M13.91%
2024-03-31$7.97M8.93%
2023-12-31$7.31M4.06%
2023-09-30$7.03M-41.42%
2023-06-30$12.00M126.19%
2023-03-31$5.30M-37.59%
2022-12-31$8.50M164.00%
2022-09-30$3.22M-56.25%
2022-06-30$7.36M238.14%
2022-03-31$2.18M-64.29%
2021-12-31$6.09M686.19%
2021-09-30$775.00K-74.73%
2021-06-30$3.07M-74.22%
2021-03-31$11.90M14587.65%
2020-12-31$81.00K-150.31%
2020-09-30$-161.00K-905.00%
2020-06-30$20.00K-79.80%
2020-03-31$99.00K-78.43%
2019-12-31$459.00K100.00%
2019-09-30-100.00%
2019-06-30--100.00%
2019-03-31$500.00K100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--

Eton Pharmaceuticals generated $22.46M in revenue during Q3 2025, up 18.65% compared to the previous quarter, and up 247.51% compared to the same period a year ago.

Eton Pharmaceuticals Revenue Breakdown

Eton Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
License$3.29M$500.00K$5.50M--
Product Sales and Royalties$76.66M$38.51M$26.14M--
Licensing Revenue---$10.00M$19.00M

Eton Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product Sales and Royalties (95.89%), and License (4.11%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 22Jun 22Dec 21Jun 21Mar 21
Product Sales and Royalties$21.28M$22.46M$18.93M$14.00M$20.72M$9.82M$7.97M-----
License-$3.29M-$500.00K--------
Licensing Revenue-------$5.00M$5.00M$5.00M$2.50M$11.50M
Royalty Revenue-----------$143.00K

Eton Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product Sales and Royalties (100.00%).

Eton Pharmaceuticals Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Jun 22Dec 21Jun 21Mar 21
Licensing Revenue$5.00M$5.00M$5.00M$2.50M$11.50M
Royalty Revenue----$143.00K

Eton Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 22: Licensing Revenue (100.00%).

Eton Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ETONEton Pharmaceuticals$79.95M$22.46M
ADCTADC Therapeutics$73.55M$15.75M
BCYCBicycle Therapeutics$72.59M$11.73M
LXRXLexicon Pharmaceuticals$49.80M$14.18M
OCGNOcugen$4.41M$1.75M
RAPTRAPT Therapeutics--
FULCFulcrum Therapeutics--
NMRANeumora Therapeutics--
OMEROmeros--
MNPRMonopar Therapeutics--

ETON Revenue FAQ

What is Eton Pharmaceuticals’s yearly revenue?

Eton Pharmaceuticals's yearly revenue for 2025 was $79.95M, representing an increase of 104.94% compared to 2024. The company's yearly revenue for 2024 was $39.01M, representing an increase of 23.29% compared to 2023. ETON's yearly revenue for 2023 was $31.64M, representing an increase of 48.90% compared to 2022.

What is Eton Pharmaceuticals’s quarterly revenue?

Eton Pharmaceuticals's quarterly revenue for Q3 2025 was $22.46M, a 18.65% increase from the previous quarter (Q2 2025), and a 117.54% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $18.93M, a 9.52% increase from the previous quarter (Q1 2025), and a 108.60% increase year-over-year (Q2 2024). ETON's quarterly revenue for Q1 2025 was $17.28M, a 48.38% increase from the previous quarter (Q4 2024), and a 116.95% increase year-over-year (Q1 2024).

What is Eton Pharmaceuticals’s revenue growth rate?

Eton Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 152.67%, and for the last 5 years (2021-2025) was 266.21%.

What are Eton Pharmaceuticals’s revenue streams?

Eton Pharmaceuticals's revenue streams in c 25 are License, and Product Sales and Royalties. License generated $3.29M in revenue, accounting 4.11% of the company's total revenue, up 557.20% year-over-year. Product Sales and Royalties generated $76.66M in revenue, accounting 95.89% of the company's total revenue, up 99.07% year-over-year.

What is Eton Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Eton Pharmaceuticals was Product Sales and Royalties. This segment made a revenue of $76.66M, representing 95.89% of the company's total revenue.